Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 22/8/2017
SIETES contiene 91973 citas

 
 
 1 a 6 de 6 
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas Cita con resumen
Köhler M, Haag S, Biester K, Brockhaus AC, McGauran N, Grouven U, Kölsch H, Seay U, Hörn H, Moritz G, Staeck K, Wieseler B. Information on new drugs at market entry: retrospective analysis of health technology assessment reports versus regulatory reports, journal publications, and registry reports. BMJ 2015;350:h796. [Ref.ID 98850]
2.Tiene citas relacionadas Cita con resumen
Wieseler B, Wolfrm N, McGauran N, Kerekes MF, Vervölgyi V, Kohlepp P, Kamphuis M, Grouven U. Completeness of reporting of patient-relevant clinical trial outcomes: comparison of unpublished clinical study reports with publicly available data. PLOS Medicine 2013:15 de octubre. [Ref.ID 96365]
3.Tiene citas relacionadas Cita con resumen
Eyding D, Lelgemann M, Grouven U, Härter M, Kromp M, Kraiser T, Kerekes MF, Gerken M, Wieseler B. Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials. BMJ 2010;341:816. [Ref.ID 89205]
4.Tiene citas relacionadas Cita con resumen
Hemkens LG, Bender R, Grouven U, Sawicki PT. Insulin glargine and cancer. Lancet 2009;374:1743-4. [Ref.ID 87228]
5.Enlace a cita originalTiene citas relacionadas Cita con resumen
Hemkens LG, Grouven U, Bender R, Günster C, Gutschmidt S, Selke GW, Sawicki PT. Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study. Diabetologia 2009;52:1732-44. [Ref.ID 86106]
6.
Bender R, Grouven U. Logistic regression models used in medical research are poorly presented. BMJ 1996;313:628. [Ref.ID 29026]
Seleccionar todas
 
 1 a 6 de 6